Scientific Intake SMARTBYTE Скачать руководство пользователя страница 1

SMART

BYTE

®

 DEVICE 

USER GUIDE

Rx Only 

Caution:  

Federal law restricts this Device to sale  

by or on the order of a physician. 

Read this information completely before  

using your SmartByte

®

 device. 

1. Indications for Use 

The SmartByte Device is intended to aid in weight management in overweight 
to obese individuals. The Device is indicated for individuals with a body 
mass index (BMI) in the range 27-35 kg/m

2

 in conjunction with behavioral 

modification instruction.

2. Description of the SmartByte Device 

The SmartByte Device is intended to be used by overweight to obese 
individuals. Overweight means a body mass index (BMI) in the range of 27-
29.9 kg/m

2

. Obese means a BMI in the range of 30-35 kg/m

2

.

The SmartByte Device will be made specifically for you to take up space in the 
upper palate (the roof) of your mouth. The Device will be made from a mold of 
your palate taken by a trained healthcare provider using the Palatal Mold Kit 
component of the Device in your healthcare practitioner’s office. The SmartByte 
Device should be worn during meals. The Device is designed to limit bite 
size and reduce the amount of food or caloric liquid consumed. The Device is 
available with wire clasps or wrap-around wires to position the Device in the 
mouth 

(Figure 1)

. The 

parts

 that occupy the space in your mouth (pink and 

clear parts in the pictures below) are the same.

Figure 1: SmartByte Device and Temperature Sensor

SmartByte Devices using the positioning clasp method (left) and wraparound method (right)

The SmartByte Device is made of acrylic. The soft edges are made of Silident 
polymers. The clasps and wraparound wires are made of Elgiloy (a type of 
flexible metal material).

The SmartByte Device contains a small sensor that measures and records 
environmental conditions (such as temperature) at 5 minute intervals and 
stores the data for up to 56 days. The sensor detects when the Device has 
been inserted in your mouth. If you wish to use the optional SmartByte Reader 
component, you will be able to track your actual Device usage.

If you desire, your healthcare provider and/or support group can also see your 
progress. The SmartByte Reader is described below.

The sensor is operated by a small 3-volt coin battery. The battery and the 
SmartByte Device have a life span of 1.2 years. The battery and sensor are 
both sealed in the Device and cannot be replaced. The only purpose of the 
sensor is to monitor Device usage. As noted above and discussed below, 
optional components (SmartByte case / reader, iPhone or Android phone app 
that can be downloaded) are available with the Device to upload and view the 
sensor data. The data provide feedback and graphs on how often you use the 
Device.

3. Contraindications, Warnings and Precautions 
Contraindications
Eating Disorder:

 Do not use the Device if you have eating disorders (such as 

anorexia nervosa (abnormally low body weight, intense fear of gaining weight, 
and distorted perception of body weight), bulimia nervosa (eat large amounts 
of food and then purge (e.g., vomit) to not gain weight). The Device is a weight 
management aid and is contraindicated (means do not use) in individuals with 
eating disorders. There may be safety risks if you have an eating disorder and 
use this Device.

Pregnancy:

 Do not use the Device if you are pregnant. The Device is a weight 

management aid and weight loss is contraindicated (means do not use) in 
pregnancy. There may be safety risks if you are pregnant and use this Device.

Warnings
Hot Liquid/Food Hazard:

 Test the temperature of any hot liquids or foods 

before drinking or eating while using the SmartByte Device. As you normally 
would when you are eating (without using the SmartByte Device), make sure 
the liquid or food is at a comfortable temperature for you to drink or eat. This 
may be different temperatures for different people. Do not swallow the liquid 
or food without sensing the temperature first. The SmartByte Device covers the 
roof of your mouth. Once the Device is in your mouth, you may not be able to 
sense the temperature of liquid or food before swallowing.

Removal at Night:

 Do not sleep with this Device in your mouth as it may 

cause breathing difficulties. The Device is intended to be used only during 
eating or drinking (caloric beverages).

Precautions
Gag Reflex:

 Ask your physician for help to see if you have a sensitive gag 

reflex. If you do, you may not be a good candidate to use this Device.

Get Used to Your Device: 

Take some time to get used to the feel of the Device 

in your mouth. You may need time to adapt to using the Device (having the 
Device in your mouth when eating or drinking).

Wear Only When Eating or Drinking Caloric Beverages:

 Remove the Device 

when finished eating or drinking. The SmartByte Device is intended to be 
placed in the mouth only during eating, including meals, snacks, and drinking 
calorie-containing beverages.

Taking Small Bites: 

Take small bites of food. Since you will have less space 

in your mouth when the SmartByte Device is in place, you will want to take 
small bites of food. If you take large bites, you might need to take some food 
out of your mouth, or you might choke or gag on the food when trying to chew 
or swallow.

Loose Fit:

 Make sure the Device feels like it fits properly and is in place in 

your mouth before you eat or drink. You should not feel the Device moving 
or wobbling in your mouth. Do not attempt to eat if the Device is loose when 
inserted, and contact your healthcare professional who prescribed the Device 
for you. The healthcare professional will arrange for the manufacturer or its 
representative to examine and, if necessary, replace or repair your Device.

Biting Down with Device in Place: 

You do not need to take any action if 

you feel contact with the Device when biting down. However, if a piece of 
the Device becomes loose (such as wobbling or falls out of place) or breaks 
off, stop using the Device. Your healthcare professional will arrange for the 
manufacturer to examine, and if necessary, replace or repair your SmartByte 
Device.

Individuals with a BMI <27 and BMI >35:

 Do not use if your BMI is <27 or > 

35 kg/ m

2

. The SmartByte Device has not been studied in these individuals.

Oral Health: 

Do not use the SmartByte Device if you have not had a dental 

examination within the last 12 months. Do not use the Device if you are not in 
good oral health. You should follow up with your dentist regularly to maintain 
oral health.

Conditions in the Oral Cavity:

 Do not use the SmartByte Device and tell your 

prescribing healthcare professional if you have any of the following conditions 
(or develop any of these conditions):

•  Deformed oral shape (e.g., bony protrusion on palate or prior surgery such 

that Device cannot sit flush against the palate)

•  Removable partial dentures (false teeth) in your upper arch (roof of mouth)

•  Inadequate oral anatomy (e.g., 3 or more loose or missing teeth on the 

upper arch, molars or pre-molars either missing or worn down to within 
4 mm above gum line, teeth with too much curvature that make placing 
and removing the Device difficult, an ore-nasal fistula (hole connecting 
the mouth and the nasal cavity) secondary to cleft palate, or a large torus 
palatinus (bony growth or protruding part on the palate))

•  Veneers (a thin covering for the front surface of a tooth)

•  Temporary crowns (tooth-shaped cap that is placed over a tooth)

•  Placement of dental implants within 12 months of Device use

•  In the process of having teeth moved or have completed a tooth moving 

procedure in the past 6 months and use any removable retainer Device 
(e.g., retainers, or aligner trays)

•  Removable or fixed bridges (replacements of missing teeth attached to the 

neighboring teeth or implant)

The SmartByte Device has not been studied in patients with these conditions. 
Patients with these conditions may not be able to properly use the SmartByte 
Device.

Other conditions: 

Tell your prescribing healthcare professional before using 

the SmartByte Device if you have or had the following conditions, or if you 
develop any of these conditions after you start using the Device:

•  Neurological disease or condition(s) (e.g., history of stroke, or other 

diseases that cause problems swallowing);

•   Diabetes;

•  Current smoker or user of smokeless tobacco or nicotine gum; or

•  Sjogren’s syndrome (immune system disorder that causes dry mouth) or 

chronic dry mouth.

The SmartByte Device has not been studied in patients with these conditions. 
There might be more risks for these patients if they use the SmartByte Device.

Risks and Benefits

The discussion provided below describes results from clinical studies 
conducted by Scientific Intake (SI). The pivotal study was the larger study of 
the Device. The confirmatory study included fewer subjects and was intended 
to confirm the findings from the larger pivotal study.

3.1. Pivotal Study

The SmartByte Device was tested in a clinical study in the United States. 
The study evaluated if the SmartByte Device is safe and helps weight 
management in 173 overweight to obese individuals. The study looked at 
people with body mass index [BMI] between 26 to 36 kg/m

2

. The study 

compared the weight loss between SmartByte Device users and control 
subjects (who did not use the SmartByte Device) after four months. Few 
SmartByte Device users had adverse events (negative side effects) related 
to the Device.

Study subjects were randomly assigned (like ‘drawing straws’) to either the 
SmartByte Device group or a control group. Device group users received 
a SmartByte Device plus nutrition, diet and exercise counseling on a DVD. 
The control group did not receive a SmartByte Device and received only 
the same nutrition, diet and exercise counseling on a DVD. The information 
contained on this DVD included guidelines for healthy eating and exercise. 
The DVD also includes information about realistic weight loss goals and 
the importance of personal and professional support systems for subjects. 
Subjects were evaluated in the 16-week study (or 4 months) every two 
weeks. During visits to the clinical site, subjects were weighed, had vital 
signs taken, and watched the counseling video. Any adverse events were 
recorded. For SmartByte Device subjects, the amount that the Device was 
used was also recorded.

SmartByte Device and control subjects were similar, including in age, 
gender, ethnic background, height, weight, and BMI.

The safety results are shown below for the full study population: 102 
subjects in the Device group and 71 in the control group. The full study 
population includes subjects who followed the protocol as well as those 
who did not use the Device as often as instructed or did not attend at least 
4 of the 7 study visits. The weight loss results are shown for the full study 
population, as well as for the subgroup of subjects who followed the study 
protocol during the 4-month study. Subjects who followed the protocol (41 
in the Device group and 67 in the control group) included subjects who used 
the Device during at least one-third (33%) of meals, and went to at least 4 
of the 7 follow-up visits. The control subjects had to attend at least 4 of 7 
visits to be considered to have followed the protocol.

Of the 173 subjects enrolled in the study, 65 subjects (61 Device subjects 
and 4 control subjects) did not use the Device as instructed, did not follow 
the protocol, or did not finish the study/attend enough visits. Subjects who 
used the SmartByte Device were supposed to wear the Device when eating 
any food and drinking any caloric liquid. Subjects in the control group did 
not use any Device, and only had to go to the clinic visits every 2 weeks and 
watch the DVD.

3.1.1 Safety

Few Device-related adverse events happened during the study. There were 
a total of 6 minor adverse events in 5 of the 102 subjects who used the 
SmartByte Device.

The minor adverse events reported included gum irritation in 2 subjects. 
There was soreness in mouth in 1 subject. One subject reported “gag 
reflex” (gagging when placing the Device in the mouth). Two subjects 
reported temporary choking on food. These events were not serious, and 
went away quickly without medical treatment.

3.1.2. Effectiveness

The benefits of the SmartByte Device were tested in a clinical study in the 
United States. The data demonstrated significantly more weight loss with 
the SmartByte Device compared to the control groups at the end of four 
months. Results measured the subjects’ total body weight loss compared to 
their body weight at baseline.

In the full study population, including those who did not use the Device as 
often as instructed or attended less than 4 of the 7 study visits, the average 
weight loss in the SmartByte Device group (102 subjects) was 1.65% 
compared to 0.36% in the control group (71 subjects). For the subjects who 
followed the protocol, the average total body weight loss in the SmartByte 
Device group (41 subjects) was 4.39% compared to 0.29% in the control 
group (67 subjects). Therefore, 4.39% total body weight loss in a subject 
who weighs 200 lbs. at baseline would translate to a weight loss of 8.8 lbs. 
with the SmartByte Device.

3.2. Confirmatory Study

Another clinical study was conducted in the United States to study the 
SmartByte Device in overweight to obese individuals whose body mass 
index [BMI] measured 27 to 35 kg/m

2

. All of the study subjects received 

the SmartByte Device plus weight loss counseling using a DVD. The DVD 
used in this study was the same used for the pivotal study. Subjects were 

evaluated in the 16-week study once every 2 weeks. During study visits, 
subjects were weighed and checked for adverse events, viewed the 
counseling DVD, and had a physical examination. All subjects received the 
SmartByte Device. The data for how often they used the Device was also 
uploaded from the Device to the health care provider’s computer during 
the visit. The study encouraged subjects to follow the protocol. The study 
emphasized that the subject needs to use the Device often to help weight 
loss. There was a screening period before subjects were qualified to join the 
study to make sure that he or she was motivated to lose weight. Subjects 
were not paid based on their amount of weight loss.

Study subjects were 20 to 49 years old and had an average BMI of 31.70 
kg/m

2

 before starting to use the SmartByte Device. The subject received 

the wraparound or side clasps version of the SmartByte Device based 
on evaluation of the subject’s oral anatomy. These two versions are very 
similar, and the safety and weight loss results were also similar.

Data about how effective the SmartByte Device is to help weight loss were 
collected. The full study population consisted of 76 subjects all in the Device 
group. The full study population includes subjects who followed the protocol 
as well as those who did not use the Device as often as instructed or did 
not complete the last study visit. The weight loss results are shown for the 
full study population, as well as for the subgroup of subjects who followed 
the study protocol during the study. Subjects who followed the protocol 
(40 of the 76 subjects) included subjects who used the Device at least 7 
times per week for at least 14 of the 16 weeks of the study, during at least 
one-third (33%) of eating episodes, and completed the last study visit at 
week 16. This use rate is lower than recommended for clinical testing 
purposes. You should use the Device during all meals and when drinking 
caloric beverages to maximize potential benefit from using the Device. The 
safety results are from all 76 subjects who received the SmartByte Device. 
Nine (9) of these 76 subjects did not complete the study due to withdrawal 
of consent (n=7), lost to follow up (n=1), and adverse event (pregnancy) 
(n=1). None of their reasons for leaving the study were due to safety events 
related to the SmartByte Device.

3.2.1. Effectiveness

As described below, the results of this study were similar to those reported 
in the other study (described above). Subjects who used the Device as 
instructed showed a consistent rate of weight loss over the 16-week period, 
and more weight loss on average compared to the full study population.

On average, the full study population lost 2.05% of their total body weight 
by the end of the study. Subjects in this group lost an average of 3.75 lbs. 
(range 9.9 lbs. weight gain to 19.4 lbs. weight loss) from their baseline 
weight. The subjects who followed the protocol lost 2.93% of their total 
body weight at the end of the study. Subjects in this group lost an average 
of 5.2 lbs. (range 9.9 lbs. weight gain to 18.7 lbs. weight loss) from their 
baseline weight.

How much weight subjects lost depended on how often they used the 
Device. For example, the 17 subjects who used the Device for 15 or more 
times per week lost an average of 6.5 pounds. The 47 subjects who used 
the Device for 7-14 times per week lost an average of 3.1 pounds (including 
the 16 subjects who showed no weight change or gained weight). The 12 
subjects who used the Device for 0-6 times per week lost an average of 2.5 
pounds (including the 7 subjects who showed no weight change or gained 
weight).

Weight loss increased over time for those who used the Device as 
instructed. Subjects who used the Device as instructed for 1 month lost 1.9 
lbs., for 2 months lost 2.1 lbs., for 3 months lost 3.2 lbs., and for 4 months 
lost 5.2 lbs. on average compared to their weight at baseline (before using 
the Device).

3.2.2. Safety

Few adverse events occurred during the study that were considered to be 
related to the Device. These events, one hard palate abrasion event (Device 
scratching the roof of the mouth) and two tongue laceration events (Device 
scratching the tongue), were not considered to be serious, and resolved 
during the study without any medical treatment. A few additional adverse 
events happened in the study that were not considered to be related to use 
of the SmartByte Device.

3.3. Risks of Device Use

The risks of using the Device, based on the events seen in the studies 
described above, are presented in Table 1. No unexpected risks were 
reported in the studies. Some of the risks below may be prevented by 
following the instructions in this manual and from your healthcare provider. 
However, there may be some risks with correct Device use too. Although 
some of these hazards were reported only for the older version of the 
Device, they may be potential risks of using the SmartByte Device.

Table 1: Risks of Device Use

Hazard

Subjects 

with Hazard

Harm/Potential Harm

Affected 

Subjects

Loose fit of Device

16 of 178 

subjects

Needed new Device

16

Device worn down  
or bending*

11 of 178 

subjects

Needed new Device

11

Soft edge 
separation**

15 of 178 

subjects

Needed new Device

15

Wire felt upon biting

8 of 178 
subjects

Needed new Device

8

Acrylic, ball clasp,  
or other breakage*

7 of 178 
subjects

Needed new Device

7

Device lost

7 of 178 
subjects

Needed new Device

7

Reaction to Device†

6 of 178 
subjects

Gag reflex upon 
insertion of the Device

1

Choked on food while 
using Device

2

Gum irritation

2

Soreness in mouth

1

Food caught in Device

5 of 178 
subjects

Needed new Device

2

Hard palate abrasion; 
temporarily suspended 
use of the Device

1

Tongue laceration 
(scratched)

2

Uncomfortable fit  
of Device

3 of 178 
subjects

Needed new Device

3

Device retained  
food flavor of previous 
meal

2 of 178 
subjects

Needed new Device

2

Device damaged by 
study subject or  
third party

2 of 178 
subjects

Needed new Device

2

Difficult removal

1 of 178 
subjects

Needed new Device

1

    * Reported in pivotal study
  ** Reported in confirmatory study
    † These reactions resolved without medication, and the subjects were able 

to continue the study.

The information in the table above is based on the first 4 months of the 
study. It is unknown what adverse events may develop after 4 months and 
how many subjects may develop them. In these studies, we did not observe 
some adverse events we thought were possible. It is not known the possible 
harm from these types of events or how often they might happen (for 
example, with longer use or more widespread use). In addition, there may 
be other risks that are not known yet.

Most of the Devices lasted throughout the clinical studies. The few Devices 
that showed breakage or separation were of the older Device design. 
For example, soft edge separation was reported for 15 subjects in the 

Sensor

Positioning Clasp

Wraparound

Отзывы: